Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,674 | -46,905 | -31,425 | -14,510 | -61,990 |
| Depreciation Amortization | 388 | 294 | 198 | 102 | 420 |
| Other Working Capital | -13,115 | -12,859 | -13,197 | -16,439 | 2,460 |
| Other Operating Activity | 1,839 | 1,299 | 1,036 | 259 | 1,880 |
| Operating Cash Flow | $-70,562 | $-58,171 | $-43,388 | $-30,588 | $-57,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -720 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-720 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 66 | N/A | 0 | N/A | N/A |
| Common Stock Repurchased | -29 | -29 | -29 | N/A | N/A |
| Other Financing Activity | 87,340 | 88,805 | 88,113 | 89,252 | 57,950 |
| Financing Cash Flow | $87,377 | $88,776 | $88,084 | $89,252 | $57,950 |
| End Cash Position | 16,815 | 30,605 | 44,696 | 58,664 | 0 |
| Net Cash Flow | $16,815 | $30,605 | $44,696 | $58,664 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,562 | -58,171 | -43,388 | -30,588 | -57,230 |
| Free Cash Flow | -70,562 | -58,171 | -43,388 | -30,588 | -57,230 |